Misonix (MSON) Reports Q1 Loss of $0.03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Misonix, Inc. Announces First Quarter Fiscal Year 2016 Financial Results
November 5, 2015 4:01 PM ESTFARMINGDALE, N.Y., Nov. 5, 2015 /PRNewswire/ --Â Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced financial results for the first quarter of fiscal year 2016 ended September 30, 2015.
Highlights for the first quarter included:
Net sales for first quarter fiscal 2016 were $5.3 million, a 16% increase, compared to $4.5 million for the same period in fiscal 2015. BoneScalpel revenue increased 30% to $2.9 million versus... More